Pharma Giant Teva Charged With Price-Fixing
The antitrust division of the U.S. Branch of Justice on Tuesday declared value fixing charges against the U.S. arm of Teva Pharmaceuticals as a feature of a years-in length, industry-wide examination concerning the counterfeit swelling of nonexclusive medication costs by a portion of the world's biggest drugmakers. Teva Pharmaceuticals USA Inc. was accused of three checks of scheming to fix costs, rig offers, and designate clients for conventional medications, the legislature said. As per the DOJ, Teva concurred with various other nonexclusive drugmakers to raise costs, rig offers, and designate clients for a wide scope of prescriptions including drugs used to treat elevated cholesterol, joint inflammation, seizures, mind malignancy, and cystic fibrosis. Website Link: https://bigwings.net/ A representative for Teva didn't promptly restore a solicitation for input. Previously, Teva has denied any bad behavior identified with value fixing and proposed that it...
Comments
Post a Comment